Joseph K Belanoff sold $2.7M of Corcept Therapeutics Incorporated (CORT)

Executed Aug 1 2025, disclosed Aug 5 2025, 4 days later.

Value, as filed

$2.7M

40,000 sh across 3 lots

Executed

Aug 1 2025

the trade date, as filed

Disclosed

Aug 5 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Joseph K Belanoff Chief Executive Officer profile →

Joseph K Belanoff (Chief Executive Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Corcept Therapeutics Incorporated (CORT). The largest single filing was $3.2M of CORT (40,000 sh × $79.77, as filed), executed Dec 1 2025.

The name

CORT

Corcept Therapeutics Incorporated CORT · Healthcare · 106 filings in 24 months ticker →

Healthcare · Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe end…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Joseph K Belanoff in CORT

CORTSALE Corcept Therapeutics Incorporated $895K
12,837 sh × $69.74
Exec Jun 1
Filed Jun 2 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $2.0M
40,000 sh × $50.10
Exec May 1
Filed May 5 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $1.3M
26,198 sh × $50.07
Exec Mar 25
Filed Mar 27 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $3.2M
40,000 sh × $79.77
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $3.0M
40,000 sh across 4 lots
Exec Nov 3 2025
Filed Nov 5 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $3.4M
40,000 sh across 3 lots
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $2.8M
39,300 sh × $70.52
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $3.3M
40,000 sh across 8 lots
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET